QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in
NASDAQ:MBRX

Moleculin Biotech SEC Filings & 10K Form

$4.56
-0.08 (-1.72 %)
(As of 02/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.55
Now: $4.56
$4.69
50-Day Range
$0.83
MA: $5.22
$6.42
52-Week Range
$1.94
Now: $4.56
$11.82
Volume1.00 million shs
Average Volume3.69 million shs
Market Capitalization$119.83 million
P/E RatioN/A
Dividend YieldN/A
Beta2.11

SEC Filings

Moleculin Biotech (NASDAQ:MBRX) SEC Filings

DateFilerForm TypeView
02/19/2021
4:01 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2021
10:28 AM
Moleculin Biotech (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2021
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2021
3:07 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2021
8:45 PM
Moleculin Biotech (Filer)
Form S-3MEF
02/02/2021
8:41 PM
Moleculin Biotech (Filer)
Form 8-K/A
02/02/2021
3:29 PM
Moleculin Biotech (Filer)
Form 424B5
02/02/2021
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2021
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2021
8:15 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/20/2021
10:14 AM
Empery Asset Management, LP (Filed by)
Moleculin Biotech (Subject)
Form SC 13G/A
01/11/2021
6:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
1:02 PM
Moleculin Biotech (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/29/2020
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2020
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2020
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2020
3:15 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2020
3:00 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2020
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2020
5:01 AM
Lincoln Park Capital Fund, LLC (Filed by)
Moleculin Biotech (Subject)
Form SC 13G
11/12/2020
3:31 PM
Moleculin Biotech (Filer)
Form 424B5
10/29/2020
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2020
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2020
3:35 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2020
6:29 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2020
4:26 PM
Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
4:25 PM
Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2020
4:02 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
3:30 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
3:04 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
3:18 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2020
3:12 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2020
3:04 PM
Moleculin Biotech (Issuer)
Priebe Waldemar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
3:31 PM
Moleculin Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/12/2020
6:32 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2020
6:29 AM
Moleculin Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/21/2020
7:41 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2020
4:19 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2020
4:16 PM
Moleculin Biotech (Filer)
Form 424B5
07/15/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2020
5:03 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2020
4:24 PM
KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2020
4:14 PM
Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2020
4:13 PM
Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
6:32 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2020
6:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2020
6:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2020
3:34 PM
CANNON MICHAEL D (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
3:32 PM
Climaco John M (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
3:30 PM
George Robert E. (Reporting)
Moleculin Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
3:20 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2020
6:32 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
4:20 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
6:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2020
6:31 AM
Moleculin Biotech (Filer)
Form DEFA14A
04/23/2020
3:06 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2020
11:15 PM
Moleculin Biotech (Filer)
Form EFFECT
04/08/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2020
3:30 PM
Moleculin Biotech (Filer)
Form DEF 14A
04/02/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2020
3:34 PM
Moleculin Biotech (Filer)
Form PRE 14A
03/19/2020
3:16 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2020
6:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2020
6:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2020
6:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2020
6:32 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2020
1:16 PM
Empery Asset Management, LP (Filed by)
Moleculin Biotech (Subject)
Form SC 13G
02/10/2020
2:17 PM
CVI Investments, Inc. (Filed by)
Moleculin Biotech (Subject)
Form SC 13G/A
02/07/2020
12:36 PM
Moleculin Biotech (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
02/06/2020
4:08 PM
Moleculin Biotech (Filer)
Form 424B5
02/05/2020
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2020
6:32 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2020
4:17 PM
Moleculin Biotech (Filer)
Form S-3/A
01/17/2020
3:37 PM
Moleculin Biotech (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/13/2020
6:01 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
3:06 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2019
6:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
6:33 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:46 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
5:33 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
5:31 AM
Moleculin Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2019
3:01 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2019
6:31 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
6:32 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2019
4:18 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2019
4:16 PM
Moleculin Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2019
6:34 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
6:48 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2019
6:30 AM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2019
6:02 AM
Moleculin Biotech (Filer)
Form 424B5
07/18/2019
3:02 PM
Moleculin Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.